Foundry Partners’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-64,512
| Closed | -$876K | – | 411 |
|
|
2020
Q2 | $876K | Sell |
64,512
-2,479
| -4% | -$33.7K | 0.04% | 314 |
|
|
2020
Q1 | $508K | Sell |
66,991
-23,643
| -26% | -$179K | 0.03% | 331 |
|
|
2019
Q4 | $573K | Sell |
90,634
-2,160
| -2% | -$13.7K | 0.02% | 339 |
|
|
2019
Q3 | $364K | Sell |
92,794
-218
| -0.2% | -$855 | 0.02% | 363 |
|
|
2019
Q2 | $450K | Sell |
93,012
-270
| -0.3% | -$1.31K | 0.02% | 349 |
|
|
2019
Q1 | $764K | Buy |
93,282
+16,222
| +21% | +$133K | 0.03% | 329 |
|
|
2018
Q4 | $426K | Sell |
77,060
-130
| -0.2% | -$719 | 0.02% | 347 |
|
|
2018
Q3 | $682K | Sell |
77,190
-120
| -0.2% | -$1.06K | 0.03% | 341 |
|
|
2018
Q2 | $772K | Buy |
77,310
+22,569
| +41% | +$225K | 0.03% | 332 |
|
|
2018
Q1 | $522K | Buy |
+54,741
| New | +$522K | 0.02% | 346 |
|